Abstract
Cholinesterase activity in the plasma of five hominoid and five cercopithecoid species was measured and characterized by profiles of inhibition by dibucaine and sodium fluoride. Chimpanzees and gorillas strongly resemble humans, and differ from other hominoids and cercopithecoids, in patterns of dibucaine and fluoride resistance and relative activity toward various thio esters. “Silent” cholinesterase phenotypes of probable veterinary significance, and analogous to a rare human variant, are apparently normal in some catarrhine species and are present as a polymorphism among orangutans and lion-tailed macaques.
Similar content being viewed by others
References
Altland, K., and Goedde, H. W. (1970). Heterogeneity in the silent gene phenotype of pseudocholinesterase of human serum.Biochem. Genet. 4: 321–338.
Altland, K., Goedde, H. W., Held, K., Jensen, M., Munsch, H., and Solem, E. (1971). New biochemical and immunological data on quantitative and qualitative variability of human pseudocholinesterase.Humangenetik 14: 56–60.
Augustinsson, K. B. (1948). Cholinesterases. A study of comparative enzymology.Acta physiol. Scand. 15: Suppl. 52.
Augustinsson, K. B. (1959). Electrophoretic studies on blood plasma esterases. I. Mammalian plasmata.Acta chem. Scand. 13: 571–592.
Augustinsson, K. B. (1961). Multiple forms of esterase in vertebrate blood plasma.Ann. N. Y. Acad. Sci. 94: 844–860.
Bourne, J. C., Collier, H. O., and Somers, G. F. (1952). Succinylcholine (succinoylcholine): Muscle relaxant of short action.Lancet 1: 1225–1229.
Breed, R. T., and Jolly, C. J. (1987). Identification and phyletic distribution of the plasma esterases of some anthropoid primates.Int. J. Primatol. 8: 331–350.
Brown, S. S., Kalow, W., Piltz, W., Whittaker, M., and Woronick, C. L. (1981). The plasma cholinesterases: A new perspective.Adv. clin. Chem. 22: 1–123.
Ellman, G. L., Coutney, D., Andres, V., and Featherstone, R. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity.Biochem. Pharmacol. 7: 88–95.
Froede, H. (1971). Acetylcholinesterase. In Boyer, P. D. (ed.),The Enzymes, Academic Press, New York, Vol. 5, pp. 87–114.
Goedde, H. W., Held, K., and Altland, K. (1968). Hydrolysis of succinyldicholine and succinylmonocholine in human serum.Mol. Pharmacol. 4: 274.
Hanssen, G. H. (1957). Cholinesterases and muscle relaxants. II. Blood and muscle cholinesterase activities in domestic animals.Acta pharmacol. toxicol. 13: 142–154.
Harris, H., and Whittaker, M. (1961). Differential inhibition of human serum cholinesterase with fluoride: Recognition of two new phenotypes.Nature (London) 191: 496–498.
Harris, H., and Whittaker, M. (1962). The serum cholinesterase variants. A study of 22 families selected via the “intermediate” phenotype.Ann. hum. Genet. 27: 53–58.
Harris, H., and Whittaker, M. (1963). Differential inhibition of “usual” and “atypical” cholinesterase by sodium chloride and sodium fluoride.Ann. hum. Genet. 27: 53–58.
Harris, H., Hopkinson, D., and Robson, E. (1962). Two-dimensional electrophoresis of pseudocholinesterase components in normal human serum.Nature (London) 196: 1296.
Harris, H., Hopkinson, D., Robson, E., and Whittaker, M. (1963). Genetical studies on a new variant of pseudocholinesterase detected by electrophoresis.Ann. hum. Genet. 26: 359–382.
Heibronn, E. (1965). Action of fluoride on cholinesterase. I. On the mechanism of inhibition.Acta chem. Scand. 19: 1333–1346.
Hobbiger, F., and Peck, A. W. (1971). Relative importance of the enzymatic hydrolysis of suxamethonium in plasma and tissue: studies in cats.Br. J. Pharmacol. 43: 341–348.
Kalow, W. (1956). The relation of plasma cholinesterases to response to clinical doses of succinylcholine.Can. anesth. Soc. J. 3: 22–30.
Kalow, W., and Davies, R. O. (1958). The activity of various esterase inhibitors towards atypical human serum cholinesterase.Biochem. Pharmacol. 1: 183–192.
Kalow, W., and Genest, K. (1957). A method for the detection of atypical forms of human serum cholinesterase. Determination of dibucaine numbers.Can. J. Biochem. Physiol. 35: 339–346.
Kalow, W., and Lindsay, H. A. (1955). A comparison of optical and manometric methods for the assay of human serum cholinesterase.Can. J. Biochem. Physiol. 33: 568–574.
Kalow, W., and Maycut, M. O. (1956). The interaction between cholinesterases and a series of local anaesthetics.J. Pharmacol. 116: 418.
Kalow, W., and Staron, N. (1957). On the distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers.Can. J. Biochem. Physiol. 35: 1305–1320.
Kalow, W., Genest, K., and Staron, N. (1956). Kinetic studies on the hydrolysis of benzoylcholine by human serum cholinesterase.Can. J. Biochem. Physiol. 34: 637–653.
Kattamis, C., Davies, D., and Lehmann, H. (1967). The silent serum cholinesterase gene.Acta genet. 17: 299.
King, A. W., and Jolly, C. J. (1983). Serogenetic analysis and conservation of the liontailed macaque. In Heltne, P. (ed.),The Liontailed Macaque, Status and Conservation (Monogr. Primatol. 7), Karger, Basel, pp. 195–219.
Krupka, R. M. (1966). Fluoride inhibition of actylcholinesterase.Mol. Pharmacol. 2: 558–569.
La Du, B. (1971). Plasma esterase activities and the metabolism of drugs with ester groups.Ann. N. Y. Acad. Sci. 179: 684–694.
La Du, B. N., Mandel, H. G., and Way, E. L. (1971).Fundamentals of Drug Metabolism and Drug Disposition, Williams and Wilkins, Baltimore.
Liddell, J., Lehman, H., and Silk, E. (1962). A “silent” gene of pseudocholinesterase.Nature (London) 193: 561.
Lockridge, O., and La Du, B. (1978). Comparison of atypical and usual human serum cholinesterase. Purification, number of active sites, substrate affinity, and turnover number.J. biol. Chem. 253: 361–366.
Lockridge, O., and La Du, B. (1982). Loss of the interchain disulfide peptide and dissociation of the tetramer following limited proteolysis of native human serum cholinesterase.J. biol. Chem. 257: 12012–12018.
Lockridge, O., Eckerson, H. W., and La Du, B. (1979). Interchain disulfide bonds and subunit organization in human serum cholinesterase.J. biol. Chem. 254: 8324–8330.
Muensch, H., Goedde, H. W., and Yoshida, A. (1976). Human serum cholinesterase subunits and number of active sites of the major component.Eur. J. Biochem. 70: 217–223.
Muensch, H., Yoshida, A., Altland, K., Jensen, W., and Goedde, H. W. (1978). Structural difference at the active site of dibucaine resistant variant of human plasma cholinesterase.Am. J. hum. Genet. 30: 302–307.
Orgell, W. H. (1963). Inhibition of human plasma cholinesterasein vitro by alkaloids, glycosides and other natural substances.Lloydia 26: 34–43.
Simpson, N. E., and Kalow, W. (1964). The “silent” gene for serum cholinesterase.Am. J. hum. Genet. 16: 180.
Stewart, D. J., Inaba, T., Tang, B. K., and Kalow, W. (1977). Hydrolysis of cocaine in human plasma by cholinesterase.Life Sci. 20: 1557–1563.
Turner, T. R. (1981). Blood protein variation in a population of vervet monkeys.Am. J. Phys. Anthrop. 55: 225–232.
Van Dyke, C., and Byck, R. (1982). Cocaine.Sci. Am. 246: 128–141.
Van Dyke, C., Barash, P. G., Jatlow, P., and Byck, R. (1976). Cocaine: Plasma concentrations after intranasal application in man.Science 191: 859–861.
van Zutphen, L. F. M. (1972). Qualitative and quantitative detection of atropinesterase and cocainesterase in two breeds of rabbits.Enzymologia 42: 201–218.
Weber, H. (1966). Rasche und einfache Ultramikromethode zur Bestimmung der Serumcholinesterase.Dtsch. med. Wschr. 91: 1927–1932.
Wright, P. G. (1981). Species variation in plasma cholinesterase activity.Comp. Biochem. Physiol. 70: 289–291.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Breed, R.T., Jolly, C.J. Variation in rates of activity and inhibition of serum cholinesterase among anthropoid primates. Int J Primatol 9, 97–112 (1988). https://doi.org/10.1007/BF02735731
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02735731